Renaissance Technologies’s Lexaria Bioscience LEXX Stock Holding History

Renaissance Technologies’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.24K	Buy	1,100 +13	+1%	+$141	﹤0.01%	3130
2026 Q1	$12.7K	Buy	1,087 +47	+5%	+$512	﹤0.01%	3192
2025 Q4	$9.63K	Buy	1,040 +367	+55%	+$5.21K	﹤0.01%	3170
2025 Q3	$9.62K	Buy	+673	New	+$9.77K	﹤0.01%	3449
2024 Q3	–	Sell	-1,520	Closed	-$63.4K	–	3735
2024 Q2	$63.4K	Buy	+1,520	New	+$68.4K	﹤0.01%	3258
2023 Q4	–	Sell	-860	Closed	-$13K	–	3947
2023 Q3	$13K	Buy	860 +147	+21%	+$2.01K	﹤0.01%	3564
2023 Q2	$8K	Sell	713 -194	-21%	-$3.77K	﹤0.01%	3834
2023 Q1	$37K	Buy	907 +140	+18%	+$5.98K	﹤0.01%	3722
2022 Q4	$28K	Sell	767 -26	-3%	-$933	﹤0.01%	3902
2022 Q3	$29K	Buy	793 +26	+3%	+$1.11K	﹤0.01%	3849
2022 Q2	$34K	Buy	+767	New	+$30.8K	﹤0.01%	4058
2021 Q3	–	Sell	-1,147	Closed	-$120K	–	3673
2021 Q2	$120K	Buy	+1,147	New	+$102K	﹤0.01%	3338

Other funds holding LEXX

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies's LEXX Position: Q2 2026 in Review

Renaissance Technologies increased its Lexaria Bioscience (LEXX) stake by 1.2% in Q2 2026, buying an estimated $141 and bringing the position to 1,100 shares worth $9.24K. The position accounts for ﹤0.01% of the portfolio, ranked #3130.

Renaissance Technologies first reported a position in LEXX in Q2 2021 and has held it in 12 quarters since. The position peaked at $120K in Q2 2021. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

Renaissance Technologies held 1,100 shares of Lexaria Bioscience worth $9.24K as of Q2 2026.
Renaissance Technologies bought 13 Lexaria Bioscience shares in Q2 2026, an estimated $141.
Lexaria Bioscience made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3130 holding.
Renaissance Technologies first reported a position in Lexaria Bioscience in Q2 2021 and has held it in 12 quarters since.
Renaissance Technologies's Lexaria Bioscience position peaked at $120K in Q2 2021.
29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.